Podcast

Industry Outlook 2022

Author(s):

Elaine Quilici,Miranda Schmalfuhs

Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; and Andy Studna, associate editor discussing various industry trends they've written up for our January issue.

You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
CSL to Layoff 15% of Employees, Close 22 US-based Plasma Centers
August 23rd 2025

CSL to Layoff 15% of Employees, Close 22 US-based Plasma Centers

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 23rd 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities
August 23rd 2025

AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities

Don Tracy, Associate Editor
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 23rd 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Stephanie J. Creary, Assistant Professor of Management at The Wharton School of The University of Pennsylvania.
August 23rd 2025

How Should BioPharma C-Suites Guide and Support Remaining Employees After Workforce Reductions?

Michael Wong
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
August 23rd 2025

Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027

Don Tracy, Associate Editor